David López

David López

Auto-generated profile, based on publicly available information

David López

Grupo México

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2025 in Nutrition in Clinical Practice
Verified
Journal Article
Open access
PSPatricia Savino‐Lloreda
Patricia Savino‐Lloreda
DLDavid López‐Daza
David López‐Daza
ACAlejandro Casas‐Herrera
Alejandro Casas‐Herrera
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous lung condition characterized by persistent airflow obstruction, associated with cardiovascular, metabolic and musculoskeletal comorbidities. In 2022, approximately 480 million people were affected by this disease, making it the third leading cause of mortality worldwide. Projections indicate that by 2050, this number could rise to 600 million. Nutrition status is a fundamental component in managing COPD patients, as it is a critical prognostic factor for morbidity and mortality. Patients with COPD may display different body composition phenotypes, ranging from cachexia to obesity to sarcopenia. Assessing body composition is essential to determine muscle mass, the latter crucial for respiratory function, and also to identify potential health risks and complications. Likewise, involuntary weight loss and decreased fat‐free mass are associated with increased mortality. COPD should be viewed as a syndrome, or as a multimorbidity coexisting with other conditions, requiring comprehensive clinical and nutrition assessment for effective management. Nutrition intervention, including oral supplements, is crucial to preserve muscle mass and weight. Supplementation with protein, ω‐3 fatty acids, and antioxidants, along with pulmonary rehabilitation, improves muscle strength and exercise tolerance. This narrative review examines nutrition phenotypes and highlights the importance of nutrition interventions in patients with COPD. A multimodal approach combining nutrition support, physical exercise, and pharmacological treatments is essential for managing COPD and its associated comorbidities.

15 February 2016 in Cureus
Verified
Journal Article
Open access
PDF file
AGAlejandro González-Motta
Alejandro González-Motta
GGGarvin González
Garvin González
YBYurany Bermudéz
Yurany Bermudéz
MMMaria C. Maldonado
Maria C. Maldonado
JCJavier M Castañeda
Javier M Castañeda
MCMartha Cotes-Mestre
Martha Cotes-Mestre
Pediatric nasopharyngeal carcinoma, also referred to as cavum carcinoma, is a rare pediatric disease with an infrequent incidence rate. We present the case of a pediatric patient with nasopharyngeal cancer who received an adult schedule of concomitant chemotherapy and conformal radiotherapy with a brachytherapy boost. Adult protocols with high radiotherapy doses are not commonly used in pediatric patients due to the high comorbidity associated with this practice. In this case, the patient displayed excellent overall survival, a longer disease-free period, and fewer side effects and comorbidities, even in the absence of interferon therapy, which is not easily available in low-income countries. In addition, this case shows that conformal radiotherapy and brachytherapy are options that can be used to escalate the radiotherapy dose and decrease side effects. A 12-year-old female pediatric patient presented to our outpatient clinic with an eight-month history of moderate-to-severe otalgia, intermittent hyaline rhinorrhea, asthenia, adynamia, nasal congestion, epistaxis in the previous months, and local pruritus. Upon physical examination, a 60x60 mm mass was detected at level II of the neck, and a biopsy of the lesion confirmed a histopathological diagnosis of undifferentiated carcinoma compatible with nasopharyngeal carcinoma. The patient was considered to have clinical Stage III cancer, and she received an adult Al-Sarraf protocol with chemoradiotherapy and an intracavitary brachytherapy boost. The patient had a complete response, and she remains without local or distance relapse. Treating pediatric nasopharyngeal carcinoma patients with the Al-Sarraf protocol could be a feasible modality, as observed in this clinical case, despite the elevated cost of using interferon-beta in low-income countries when using more advanced radiotherapy techniques such as conformal radiotherapy and now, modulated intensity radiotherapy. It should be noted that brachytherapy boosts should be used with caution in pediatric patients; the potential side effects should be weighed against improved local control.

1 July 2015 in Revista Colombiana de Cancerología
Verified
Journal Article
Closed access
JAJavier Angel
Javier Angel
JIJohanna Ibarra
Johanna Ibarra
SDSandra Diaz
Sandra Diaz
CLCarlos Lehmann
Carlos Lehmann
MGMauricio Garcia
Mauricio Garcia
DLDavid Lopez
David Lopez

1 January 2017 in Revista Colombiana de Cancerología
Verified
Journal Article
Closed access
NRNory Rodríguez
Nory Rodríguez
MAMartha Argüello
Martha Argüello
DLDavid López
David López

8 October 2015 in Revista de Salud Pública
Verified
Journal Article
Closed access
DDDavid López Daza
David López Daza
MJMiguel Castro Jímenez
Miguel Castro Jímenez
Objetivo Establecer características y tendencia de la mortalidad por cáncer de tiroides en Colombia.Materiales y Métodos Estudio de la mortalidad por cáncer de tiroides empleando las bases oficiales nacionales de muertes en Colombia (1998-2010). Se analizaron año de defunción, sexo, edad y departamento de residencia. Se utilizaron proporciones, media aritmética y mediana. El valor de p límite para significación estadística fue 0,05. Se calcularon tasas crudas, específicas y ajustadas por edad.Resultados En total, 2 570 personas, 1 827 (71,1 %) muertes ocurrieron en mujeres. Las edades medianas a la muerte fueron de 68 años en hombres y de 70 años en mujeres. La tasa anual media de mortalidad por cáncer de tiroides ajustada (2006-2010) fue de 0,52 muertes por 100 000 personas (ambos sexos), 0,32 muertes por 100 000 hombres y 0,70 por 100 000 mujeres.Conclusiones Deben realizarse estudios que muestren posibles factores asociados a muerte a más temprana edad en mujeres colombianas.

1 December 2013 in Revista Colombiana de Cancerología
Verified
Journal Article
Closed access
RCRicardo Alfonso Merchán Chaverra
Ricardo Alfonso Merchán Chaverra
DDDavid Fernando López Daza
David Fernando López Daza
ARAndrés Leonardo González Rangel
Andrés Leonardo González Rangel